×
About 48,145 results

ALLMedicine™ Dopamine Center

Research & Reviews  16,861 results

Recovery of dopaminergic system after cocaine exposure and impact of a long-acting coca...
https://doi.org/10.1111/adb.13179
Addiction Biology; Deng J, Zhang T et. al.

Jun 28th, 2022 - Dysregulation of dopamine transporters (DAT) within the dopaminergic system is an important biomarker of cocaine exposure. Depending on cocaine amount in-taken, one-time exposure in rats could lead to most (>95% of total) of DAT translocating to p...

Ectopic Cavernous Sinus Microprolactinoma Treated Medically.
https://doi.org/10.1093/milmed/usac182
Military Medicine; Minns RM, Barranco-Trabi J et. al.

Jun 28th, 2022 - Ectopic prolactin-secreting microadenomas are rare and management is often surgical in contrast to intrasellar pituitary prolactin-secreting microadenomas. We present a case of ectopic dopamine-resistant microprolactinoma treated with cabergoline ...

Cognitive control inhibition networks in adulthood are impaired by early iron deficienc...
https://doi.org/10.1016/j.nicl.2022.103089
NeuroImage. Clinical; Cecilia A, Patricio P et. al.

Jun 27th, 2022 - Iron deficiency, a common form of micronutrient deficiency, primarily affects children and women. The principal cause of iron deficiency is undernutrition in low-income countries and malnutrition in middle to upper income regions. Iron is a key el...

Alpha-2 Adrenoreceptor Antagonist Yohimbine Potentiates Consolidation of Conditioned Fear.
https://doi.org/10.1093/ijnp/pyac038
The International Journal of Neuropsychopharmacology; Sperl MFJ, Panitz C et. al.

Jun 25th, 2022 - Hyperconsolidation of aversive associations and poor extinction learning have been hypothesized to be crucial in the acquisition of pathological fear. Previous animal and human research points to the potential role of the catecholaminergic system,...

Systemic D1-R and D2-R antagonists in Non-Human Primates Differentially Impact Learning...
https://doi.org/10.1111/ejn.15743
The European Journal of Neuroscience; Marino RA, Gaprielian P et. al.

Jun 25th, 2022 - Dopamine (DA) modulates cognition in part via differential activation of D1 and D2 receptors within the striatum and prefrontal cortex, yet evidence for cognitive impairments stemming from DA blockade or deficiency is inconsistent. Given the predo...

see more →

Guidelines  4 results

Evidence-based clinical practice guidelines for functional dyspepsia 2021.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831363
Journal of Gastroenterology; Miwa H, Nagahara A et. al.

Jan 22nd, 2022 - Functional dyspepsia (FD) is a disorder that presents with chronic dyspepsia, which is not only very common but also highly affects quality of life of the patients. In Japan, FD became a disease name for national insurance in 2013, and has been gr...

Expert consensus document: A consensus on the medical treatment of acromegaly.
https://doi.org/10.1038/nrendo.2014.21
Nature Reviews. Endocrinology; Giustina A, Chanson P et. al.

Feb 26th, 2014 - In March 2013, the Acromegaly Consensus Group met to revise and update guidelines for the medical treatment of acromegaly. The meeting comprised experts skilled in the medical management of acromegaly. The group considered treatment goals covering...

Surviving sepsis campaign: international guidelines for management of severe sepsis and...
https://doi.org/10.1097/CCM.0b013e31827e83af
Critical Care Medicine; Dellinger RP, Levy MM et. al.

Jan 29th, 2013 - To provide an update to the "Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock," last published in 2008. A consensus committee of 68 international experts representing 30 international organizations was convened...

Acute emesis: moderately emetogenic chemotherapy.
https://doi.org/10.1007/s00520-010-0951-5
Supportive Care in Cancer : Official Journal of the Multi... Herrstedt J, Rapoport B et. al.

Aug 4th, 2010 - This paper is a review of the recommendations for the prophylaxis of acute emesis induced by moderately emetogenic chemotherapy as concluded at the third Perugia Consensus Conference, which took place in June 2009. The review will focus on new stu...

see more →

Drugs  295 results see all →

Clinicaltrials.gov  1,214 results

Brain Dopamine Function in Human Obesity
https://clinicaltrials.gov/ct2/show/NCT03648892

Jun 24th, 2022 - Evidence from neuroimaging studies indicates that aberrant functionality in brain regions that support reward processing and habit formation may be related to an individual's eating behavior and obesity propensity. In particular, our previous rese...

Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
https://clinicaltrials.gov/ct2/show/NCT00942981

Jun 24th, 2022 - OBJECTIVES Dopaminergic (DA) modulation of brain function is disturbed in several disabling psychiatric disorders and represents the target of key psychopharmacologic agents, such as neuroleptics. Schizophrenia has been considered a prototype of d...

Brain Dopaminergic Signaling in Opioid Use Disorders
https://clinicaltrials.gov/ct2/show/NCT03190954

Jun 24th, 2022 - Objectives: Primary objective is to assess whether the balance between dopamine D1 (D1R) and D2 receptors (D2R) signaling in striatum is disrupted in participants with an opioid use disorder (OUD) who are on opioid agonist medication (MAT+: methad...

Neural Basis of Decision-Making Deficits in Traumatic Brain Injury
https://clinicaltrials.gov/ct2/show/NCT02169310

Jun 24th, 2022 - Study Description: Deficits in decision-making are commonly found in individuals after traumatic brain injury (TBI) and can have a severe negative impact on quality of life. Converging evidence from both animal model and human studies suggest that...

Dopamine Rhythms in Health and Addiction
https://clinicaltrials.gov/ct2/show/NCT02233829

Jun 24th, 2022 - Objectives: The primary objective is to assess if there is disruption of circadian DA rhythms in cocaine addiction. The secondary objective is to assess if dopamine modulates the sensitivity of the brain reward network in a circadian dependent man...

see more →

News  873 results

Drinking Coffee Before Shopping Can Increase Spending
https://www.medscape.com/viewarticle/975998

Jun 22nd, 2022 - Caffeine doesn't just stimulate the senses; it can stimulate a person's impulsiveness when it comes to shopping, according to researchers from the University of South Florida. What to know: Caffeine is a powerful stimulant that releases dopamine i...

Lower-Dose Antipsychotics Benefit Patients with Schizophrenia in Long-Term Care
https://www.medscape.com/viewarticle/975799

Jun 17th, 2022 - NEW ORLEANS — Patients with treatment-refractory schizophrenia in a long-term forensic facility showed significant stabilization following reduced doses of long-acting injectable antipsychotics, a study revealed. Dr Mujeeb Shad "There is an argume...

Schizophrenia patients in long-term facilities benefit from lower-dose antipsychotics
https://www.mdedge.com/psychiatry/article/255297/schizophrenia-other-psychotic-disorders/schizophrenia-patients-long-term
Nancy A. Melville

Jun 8th, 2022 - NEW ORLEANS – Patients with treatment-refractory schizophrenia in a long-term forensic facility showed significant stabilization following reduced doses of long-acting injectable antipsychotics, a study revealed. “There is an argument by some expe.

Neurotransmitter-based diagnosis and treatment: A hypothesis (Part 2)
https://www.mdedge.com/psychiatry/article/254984/neurotransmitter-based-diagnosis-and-treatment-hypothesis-part-2
Dmitry M. Arbuck, MD, José Miguel Salmerón, MD et. al.

Jun 1st, 2022 - There is a need to connect mental and physical symptoms in the diagnosis and treatment of psychiatric disorders. Obviously, we are not yet equipped to clearly recognize which neurotransmitters cause which symptoms.

Cabergoline Improves Metabolic Status in Hyperprolactinemia
https://www.medscape.com/viewarticle/974577

May 25th, 2022 - Researchers published the study covered in this summary on medRxiv.org as a preprint that has not yet been peer reviewed. Key Takeaways Patients with hyperprolactinemia secondary to a newly diagnosed prolactinoma who received 6 months of treatment...

see more →

Patient Education  11 results see all →